Home Search
cannabis - search results
If you're not happy with the results, please do another search
ECH announces plans to open first UK medical cannabis clinics
European Cannabis Holdings (ECH) has announced plans to open The Medical Cannabis Clinics in a step toward aiding patients living with a range of chronic conditions.
80% of people willing to ask doctor about medicinal cannabis
A survey by Rehab 4 Addiction using Facebook reveals more than 80% of people aged 55+ are contemplating asking their doctor about medicinal cannabis following the upcoming the change that’s due to kick in next week
Medicinal cannabis-based products to be made available on prescription
Home secretary, Sajid Javid has announced that medicinal products that derive from cannabis will be made available on prescription by Autumn.
Cannabis: One of the most thoroughly studied plants ever
David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time
How trusted data is helping to liberate the power of medical cannabis
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Cannabis developments in North America
Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today
Medical cannabis advocacy and education
Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues
How blockchain could transform the cannabis industry
Rising blockchain technology could be a game changer for legal marijuana, according to small-cap cannabis stock Emerald Health Therapeutics
North America Analysis April 2024
Open Access Government encourages you to read our latest North America Analysis after Easter, which provides fascinating insights from leading experts and researchers on crucial policy topics.
Designing out crime: a strategic approach to reducing youth crime rates and boosting mental...
Sarah Nelson, CEO of Foundation for Future London, discusses innovative ways to ‘design out crime’ to reduce crime rates and youth substance abuse in East London.
The opioid crisis in canada – Governmental responses and strategies
Norm Buckley, Scientific Director at the Michael G. DeGroote Institute for Pain Research & Care, and Jason Busse, Director of the Michael G DeGroote National Pain Centre at McMaster University, discuss the complexities of chronic pain management and addressing the opioid crisis.
Therapeutic potential of the endocannabinoid system to treat chronic pain in inflammatory disease
Pharma researchers Julie Blaising and Philip Smith from F. Hoffmann-La Roche Ltd. discuss the endocannabinoid system as a pathway to treat inflammatory diseases such as Inflammatory Bowel Disease (IBD) and endometriosis.
Is there a link between air pollution and cardiovascular deaths?
The World Health Organization (WHO) has revealed that air pollution is significantly linked to mortality from cardiovascular diseases, with low-income countries taking the burden of its impact.
North America Analysis January 2024
Happy New Year from Open Access Government! We invite you to celebrate by reading North America Analysis’s January 2024 volume, which offers compelling observations from distinguished subject matter experts and researchers.
The extent and impact of the opioid crisis in Canada
The opioid crisis in Canada has been an issue for nearly a quarter of a century. Here, Norm Buckley and Jason Busse from the Michael G DeGroote Institute for Pain Research and Care, and the National Pain Centre discuss the issue, its effects both general and on specific communities, and what can be done about it.
Promoting fathers’ mental health and involvement
Promoting fathers’ mental health and father involvement – a call to action is given here by Deborah Da Costa, Ph.D., Associate Professor at the Department of Medicine, McGill University, and Scientist at McGill University Health Centre.
Understanding glioma-related epilepsy: Ongoing research and treatments
UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
CBD and growing trust: Sowing the seeds of good health
Over the past seven years, CBD wellness company Savage Cabbage has grown from a small family-run business into a globally recognised, high-quality brand, trusted as an authoritative voice, even in the corridors of Westminster.
SARMs and CBD: When food regulation is hard to swallow
SARMs and CBD: Navigating Regulatory Gaps in UK's Food Industry - Unusual products blur the lines between food and medicine, prompting questions about effective regulation.
What is the Psychedelic Renaissance and what can we learn from its history
Psychedelic therapies are breathing optimism back into modern psychiatry. Substances like psilocybin mushrooms, MDMA, and ketamine are showing clinical promise in a number of treatment-resistant categories of mental disorders, and we are beginning to see a psychedelic renaissance.